XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Herve Hoppenot [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Hervé Hoppenot, a director and the Special Advisor to the Chief Executive Officer, adopted a trading plan on August 11, 2025 providing for the sale of up to an aggregate of 187,500 shares of our common stock until August 11, 2026.
Name Hervé Hoppenot
Title director and the Special Advisor to the Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 11, 2025
Expiration Date August 11, 2026
Arrangement Duration 365 days
Aggregate Available 187,500
Steven Stein [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Steven Stein, our Executive Vice President and Chief Medical Officer, adopted a trading plan on August 6, 2025 providing for the sale of up to an aggregate of 69,435 shares of our common stock until August 6, 2026.
Name Steven Stein
Title Executive Vice President and Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 6, 2025
Expiration Date August 6, 2026
Arrangement Duration 365 days
Aggregate Available 69,435
Lee Heeson [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Lee Heeson, our Executive Vice President and Head of Incyte International, adopted a trading plan on August 4, 2025 providing for the sale of up to an aggregate of 3,074 shares of our common stock until August 4, 2026.
Name Lee Heeson
Title Executive Vice President and Head of Incyte International
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 4, 2025
Expiration Date August 4, 2026
Arrangement Duration 365 days
Aggregate Available 3,074
Thomas Tray [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Thomas Tray, our Vice President, Chief Accounting Officer, adopted a trading plan on August 22, 2025 providing for the sale of up to an aggregate of 4,143 shares of our common stock until August 24, 2026.
Name Thomas Tray
Title Vice President, Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 22, 2025
Expiration Date August 24, 2026
Arrangement Duration 367 days
Aggregate Available 4,143
Patrick Mayes [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Patrick Mayes, our Executive Vice President, Chief Scientific Officer, adopted a trading plan on September 8, 2025 providing for the sale of up to an aggregate of 5,750 shares of our common stock until September 8, 2026.
Name Patrick Mayes
Title Executive Vice President, Chief Scientific Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date September 8, 2025
Expiration Date September 8, 2026
Arrangement Duration 365 days
Aggregate Available 5,750
Michael Morrissey [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Michael Morrissey, our Executive Vice President, Head of Global Technical Operations, adopted a trading plan on September 16, 2025 providing for the sale of up to an aggregate of 58,331 shares of our common stock until September 16, 2026.
Name Michael Morrissey
Title Executive Vice President, Head of Global Technical Operations
Rule 10b5-1 Arrangement Adopted true
Adoption Date September 16, 2025
Expiration Date September 16, 2026
Arrangement Duration 365 days
Aggregate Available 58,331
Mohamed Issa [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Mohamed Issa, our Executive Vice President, Head of US Oncology, adopted a trading plan on September 15, 2025 providing for the sale of up to an aggregate of 11,813 shares of our common stock until September 15, 2026.
Name Mohamed Issa
Title Executive Vice President, Head of US Oncology
Rule 10b5-1 Arrangement Adopted true
Adoption Date September 15, 2025
Expiration Date September 15, 2026
Arrangement Duration 365 days
Aggregate Available 11,813